PM,
If there were another device that could do what FlaskWorks does don't you think someone here would know about it and tell us to also look at the competition. Is there anyone else making a personalized product that has an automated way of doing so? I'm no expert, I don't know of any, but perhaps someone here does, we have experts here in many related fields.
By the way, I'll agree with you in part that LP has very possibly spoken with companies interested in partnering, or buying out NWBO. I don't believe, as you do, that terms have been finalized. I believe that they've said something like, after you've gotten approval from one or more of the regulators, let's get together again and talk it over. I'm not saying it must be one or more approvals, it could be something more, or less, and it might be based more on stock price or market cap than a specific event. I believe that LP may have put an approximate price out there and gotten a response that essentially said let's talk seriously when your market cap is a reasonable fraction of that price.
When it comes to achieving a specific stock price I don't believe you can ever rule out a major surprise. Major media coverage of an otherwise unknown company or drug has on numerous occasions sent a stock through the roof. We may know a great deal about NWBO, but 99%+ of the investing public has never heard of it. I don't believe that our Phase 3 Trial results in such a story, but I believe that when you combine it with the work being done at UCLA that take 5 year survival to 50% or more you have the makings of such a story. The story won't be told by Dr. Liau, or the other scientists at UCLA, they've already put it out their in scientific presentations, it needs to be picked up by the right person in the media, then you could have a story that's seen all over the world.
Gary
Bullish